CAS No – 2227366-51-8

Status – Pre-Valdation

Product Description

Dalbavancin hydrochloride is a lipoglycopeptide antibiotic used to treat acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible strains of Gram-positive bacteria. It’s a second-generation lipoglycopeptide designed to improve upon natural glycopeptides like vancomycin, offering increased activity and once-weekly dosing.